Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting

BACKGROUND: Many clinicians and insurance providers are reluctant to embrace recent guidelines identifying people who inject drugs (PWID) as a priority population to receive hepatitis C virus (HCV) treatment. The aim of this study was to evaluate the efficacy of direct-acting antiviral (DAA) HCV the...

Descripción completa

Detalles Bibliográficos
Autores principales: Alimohammadi, Arshia, Holeksa, Julie, Thiam, Astou, Truong, David, Conway, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022542/
https://www.ncbi.nlm.nih.gov/pubmed/29992173
http://dx.doi.org/10.1093/ofid/ofy120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022542/
https://www.ncbi.nlm.nih.gov/pubmed/29992173
http://dx.doi.org/10.1093/ofid/ofy120

Ejemplares similares